Roxas, Antonio, JR.. D.
HRN: 25-17-77 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2024
METRONIDAZOLE 500MG (TAB)
06/07/2024
06/13/2024
PO
500 Mg/tab, 1 Tab
Q8
H. Pylori Infection;
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes